Ranbaxy Pharmaceuticals Inc

Prolong Pharmaceuticals, LLC, based in South Plainfield, NJ, is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for complex diseases, including ischemia, hypoxia within stroke, sickle cell disease, and cystic fibrosis. With a leadership team experienced in biotechnology and a pioneering approach to PEGylation, Prolong aims to meet critical unmet medical needs through its cutting-edge biopharma solutions. The company's flagship product, PP-007 Sanguinate, employs a novel PEGylated technology to restore homeostasis by delivering oxygen to hypoxic tissues and facilitating improved perfusion while reducing inflammation. Prolong Pharmaceuticals is committed to advancing healthcare through groundbreaking therapies targeting severe and life-threatening conditions, with a strong focus on addressing the global health issue of stroke. Generated from the website

Abeille Pharmaceuticals Inc is a research-driven company based in Princeton, NJ, specializing in the development of innovative pharmaceutical products. With a focus on cutting-edge technology and scientific advancements, Abeille Pharmaceuticals Inc is dedicated to improving healthcare outcomes for patients worldwide. Committed to excellence in drug discovery and development, Abeille Pharmaceuticals Inc collaborates with leading experts in the field to bring novel therapies to market. Through a combination of expertise and strategic partnerships, the company strives to address unmet medical needs and make a meaningful impact on global health. Generated from their business information

Novo Nordisk Pharmaceuticals, headquartered in Princeton, NJ, is a global leader in the development of innovative medicines, particularly in the fields of obesity and cardiometabolic diseases. The company is committed to redefining obesity care and advancing treatment options through scientific research and collaboration. With a strong focus on sustainable business practices, Novo Nordisk aims to improve patient outcomes while maintaining a robust pipeline of products. The company continues to expand its reach and impact in the healthcare sector, reflecting its dedication to addressing pressing medical needs. Generated from the website